Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akso Health Group stock logo
AHG
Akso Health Group
$1.47
-15.5%
$1.31
$0.62
$2.35
$253.56M-0.1968,540 shs12,938 shs
DLH Holdings Corp. stock logo
DLHC
DLH
$5.08
+0.2%
$4.06
$2.72
$12.23
$73.08M1.3354,276 shs46,811 shs
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$2.30
-0.4%
$2.53
$2.10
$5.26
$245.60M1.38599,708 shs1.15 million shs
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
$10.91
$10.91
$10.35
$11.93
$283.07M-0.0231,316 shsN/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akso Health Group stock logo
AHG
Akso Health Group
-14.53%-17.42%+8.09%+8.89%+31.25%
DLH Holdings Corp. stock logo
DLHC
DLH
+0.20%+0.79%+28.93%+0.40%-54.15%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-0.43%+5.02%-19.01%-31.14%-50.85%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Akso Health Group stock logo
AHG
Akso Health Group
0.767 of 5 stars
0.05.00.00.02.90.00.0
DLH Holdings Corp. stock logo
DLHC
DLH
2.5897 of 5 stars
0.02.00.00.03.44.21.9
MaxCyte, Inc. stock logo
MXCT
MaxCyte
2.5695 of 5 stars
3.52.00.00.02.72.50.6
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akso Health Group stock logo
AHG
Akso Health Group
0.00
N/AN/AN/A
DLH Holdings Corp. stock logo
DLHC
DLH
0.00
N/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.00
Buy$7.50226.09% Upside
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest DLHC, SHAP, AHG, and MXCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$6.00
3/12/2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $9.00
(Data available from 5/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akso Health Group stock logo
AHG
Akso Health Group
$8.45M25.34N/AN/A$0.95 per share1.55
DLH Holdings Corp. stock logo
DLHC
DLH
$377.07M0.19$1.68 per share3.03$7.75 per share0.66
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$37.68M6.49N/AN/A$2.23 per share1.03
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/A($0.47) per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akso Health Group stock logo
AHG
Akso Health Group
-$9.46MN/A0.00N/AN/AN/AN/AN/A
DLH Holdings Corp. stock logo
DLHC
DLH
$7.40M$0.3811.55N/AN/A1.64%5.82%1.97%7/30/2025 (Estimated)
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$37.92M-$0.40N/AN/AN/A-78.36%-16.00%-13.93%8/5/2025 (Estimated)
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
$4.35MN/A0.00N/AN/A-22.17%6.72%N/A

Latest DLHC, SHAP, AHG, and MXCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q2 2025
DLH Holdings Corp. stock logo
DLHC
DLH
$0.07$0.06-$0.01$0.06$90.00 million$89.21 million
5/7/2025Q1 2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.10-$0.10N/A-$0.10$9.05 million$10.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Akso Health Group stock logo
AHG
Akso Health Group
N/AN/AN/AN/AN/A
DLH Holdings Corp. stock logo
DLHC
DLH
N/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/AN/AN/AN/AN/A
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akso Health Group stock logo
AHG
Akso Health Group
N/AN/AN/A
DLH Holdings Corp. stock logo
DLHC
DLH
1.21
1.04
1.04
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/A
9.81
9.22
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/A
6.19
6.19

Institutional Ownership

CompanyInstitutional Ownership
Akso Health Group stock logo
AHG
Akso Health Group
1.21%
DLH Holdings Corp. stock logo
DLHC
DLH
67.25%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
68.81%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
9.94%

Insider Ownership

CompanyInsider Ownership
Akso Health Group stock logo
AHG
Akso Health Group
N/A
DLH Holdings Corp. stock logo
DLHC
DLH
15.30%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.00%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
58.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Akso Health Group stock logo
AHG
Akso Health Group
40145.72 millionN/ANot Optionable
DLH Holdings Corp. stock logo
DLHC
DLH
2,40014.39 million12.19 millionOptionable
MaxCyte, Inc. stock logo
MXCT
MaxCyte
80106.32 million102.67 millionOptionable
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/A25.95 million10.79 millionNot Optionable

Recent News About These Companies

Senior journalist Kandula Subramaniam passes away
Launch One Acquisition Corp. Cl A
Global borrowing blitz led by blue chips selling $43bn
Launch One Acquisition Corp. - Ordinary Shares - Class A
Boost for Rachel Reeves as borrowing costs fall

New MarketBeat Followers Over Time

Media Sentiment Over Time

Akso Health Group stock logo

Akso Health Group NASDAQ:AHG

$1.47 -0.27 (-15.52%)
Closing price 05/30/2025 03:57 PM Eastern
Extended Trading
$1.53 +0.06 (+4.15%)
As of 05/30/2025 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

DLH stock logo

DLH NASDAQ:DLHC

$5.08 +0.01 (+0.20%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$5.01 -0.07 (-1.28%)
As of 05/30/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DLH Holdings Corp. provides technology-enabled business process outsourcing, program management solutions, and public health research and analytics services in the United States. It offers digital transformation and cyber security solutions, including artificial intelligence and machine learning, cloud enablement, cybersecurity ecosystem, big data analytics, and modeling and simulation to the National Institutes of Health (NIH), the Defense Health Agency, Tele-medicine and Advanced Technology Research Center, and US Navy Naval Information Warfare Center (NIWC). The company also provides science research and development services and solutions, such as data analytics, testing and evaluation, clinical trials research services, and epidemiology studies to support multiple operating divisions, including NIH and the Center for Disease Control and Prevention, as well as the Military Health System. In addition, it offers system engineering and integration solutions in the areas of pharmaceutical delivery logistics, fire protection engineering, biomedical equipment, and technology engineering on behalf of the Department of Veterans Affairs, NIWC, Health and Human Services, and other federal customers. The company also provides business process management services under the trademarks, e-PRAT and SPOT-m, as well as the registered trademark, Infinibyte for cloud-based solutions. The company was formerly known as TeamStaff, Inc. and changed its name to DLH Holdings Corp. in June 2012. DLH Holdings Corp. was incorporated in 1969 and is headquartered in Atlanta, Georgia.

MaxCyte stock logo

MaxCyte NASDAQ:MXCT

$2.30 -0.01 (-0.43%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$2.38 +0.08 (+3.48%)
As of 05/30/2025 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Spree Acquisition Corp. 1 stock logo

Spree Acquisition Corp. 1 NYSE:SHAP

$10.91 0.00 (0.00%)
As of 05/29/2025

Spree Acquisition Corp. 1 Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the mobility-related technology businesses. The company was incorporated in 2021 and is based in Atlanta, Georgia.